HK1068798A1 - Antibodies for inhibiting blood coagulation and methods of use thereof - Google Patents

Antibodies for inhibiting blood coagulation and methods of use thereof

Info

Publication number
HK1068798A1
HK1068798A1 HK05101282.0A HK05101282A HK1068798A1 HK 1068798 A1 HK1068798 A1 HK 1068798A1 HK 05101282 A HK05101282 A HK 05101282A HK 1068798 A1 HK1068798 A1 HK 1068798A1
Authority
HK
Hong Kong
Prior art keywords
antibodies
blood coagulation
native human
bind
methods
Prior art date
Application number
HK05101282.0A
Other languages
English (en)
Inventor
Jin-An Jiao
Hing C Wong
Esperanza Liliana Nieves
Luis A Mosquera
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/990,586 external-priority patent/US20030109680A1/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of HK1068798A1 publication Critical patent/HK1068798A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/467—Igs with modifications in the FR-residues only
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK05101282.0A 2001-10-29 2005-02-16 Antibodies for inhibiting blood coagulation and methods of use thereof HK1068798A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34330601P 2001-10-29 2001-10-29
US09/990,586 US20030109680A1 (en) 2001-11-21 2001-11-21 Antibodies for inhibiting blood coagulation and methods of use thereof
PCT/US2002/034727 WO2003037911A2 (en) 2001-10-29 2002-10-29 Antibodies for inhibiting blood coagulation and methods of use thereof

Publications (1)

Publication Number Publication Date
HK1068798A1 true HK1068798A1 (en) 2005-05-06

Family

ID=26993414

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05101282.0A HK1068798A1 (en) 2001-10-29 2005-02-16 Antibodies for inhibiting blood coagulation and methods of use thereof

Country Status (11)

Country Link
EP (1) EP1446157B1 (xx)
JP (1) JP4439914B2 (xx)
KR (1) KR100951432B1 (xx)
CN (1) CN100575364C (xx)
AT (1) ATE493148T1 (xx)
CA (1) CA2465325C (xx)
DE (1) DE60238782D1 (xx)
DK (1) DK1446157T3 (xx)
HK (1) HK1068798A1 (xx)
TW (1) TWI338009B (xx)
WO (1) WO2003037911A2 (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7749498B2 (en) 1997-03-10 2010-07-06 Genentech, Inc. Antibodies for inhibiting blood coagulation and methods of use thereof
US5986065A (en) 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US20030109680A1 (en) 2001-11-21 2003-06-12 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US20060235209A9 (en) 1997-03-10 2006-10-19 Jin-An Jiao Use of anti-tissue factor antibodies for treating thromboses
US6703494B2 (en) 2000-03-16 2004-03-09 Genentech, Inc. Anti-tissue factor antibodies with enhanced anticoagulant potency
US20030190705A1 (en) 2001-10-29 2003-10-09 Sunol Molecular Corporation Method of humanizing immune system molecules
US7579000B2 (en) 2002-05-01 2009-08-25 Bayer Schering Pharma Ag Tissue factor targeted antibodies as anticoagulants
UA81114C2 (en) * 2002-05-01 2007-12-10 Schering Ag Novel antibodies to tissue factor as anticoagulants
WO2004039842A2 (en) * 2002-10-31 2004-05-13 Novo Nordisk A/S Humanized tissue factor antibodies
US7425328B2 (en) 2003-04-22 2008-09-16 Purdue Pharma L.P. Tissue factor antibodies and uses thereof
US9708410B2 (en) 2003-05-30 2017-07-18 Janssen Biotech, Inc. Anti-tissue factor antibodies and compositions
WO2004110363A2 (en) * 2003-05-30 2004-12-23 Centocor, Inc. Method of inhibiting tumor growth with anti-tissue factor antibodies
US7605235B2 (en) 2003-05-30 2009-10-20 Centocor, Inc. Anti-tissue factor antibodies and compositions
JP5114055B2 (ja) * 2003-06-19 2013-01-09 ジェネンテック， インク． 障害に関連する凝固の治療用組成物および方法
EP1749536A1 (en) * 2005-08-03 2007-02-07 Thrombotargets Europe, S.L. Activated factor X stimulants as new antihemorrhagic agents for topical use
UA109633C2 (uk) 2008-12-09 2015-09-25 Антитіло людини проти тканинного фактора
NO2582728T3 (xx) 2010-06-15 2018-01-20
US8722044B2 (en) 2011-03-15 2014-05-13 Janssen Biotech, Inc. Human tissue factor antibody and uses thereof
GB201121513D0 (en) * 2011-12-14 2012-01-25 Cambridge Entpr Ltd Thrombin-binding antibody molecules and uses thereof
US9518128B2 (en) 2011-12-14 2016-12-13 Janssen Pharmaceuticals, Inc. Thrombin-binding antibody molecules
KR102267292B1 (ko) 2013-03-15 2021-06-21 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 미토콘드리아 유래의 펩티드 ｍｏｔｓ3에 의해 조절되는 물질대사 및 세포 생존
JP5957637B2 (ja) * 2014-02-03 2016-07-27 国立研究開発法人国立がん研究センター 抗ＴｉｓｓｕｅＦａｃｔｏｒモノクローナル抗体
JP7073253B2 (ja) * 2015-08-21 2022-05-23 エフ．ホフマン－ラ ロシュ アーゲー アフィニティークロマトグラフィーにおける宿主細胞タンパク質の低減方法
CN107446047B (zh) * 2017-09-04 2020-08-11 山西省生物研究院有限公司 一种双功能性抗组织因子人源化抗体及其制备方法
CN113015744A (zh) 2018-08-30 2021-06-22 Hcw生物科技公司 单链嵌合多肽和多链嵌合多肽以及其用途
AU2019328290A1 (en) 2018-08-30 2021-02-25 HCW Biologics, Inc. Multi-chain chimeric polypeptides and uses thereof
KR20210069639A (ko) 2018-08-30 2021-06-11 에이치씨더블유 바이올로직스, 인크. 단일-사슬 키메라 폴리펩타이드 및 이의 용도
CA3143035A1 (en) 2019-06-21 2020-12-24 HCW Biologics, Inc. Multi-chain chimeric polypeptides and uses thereof
CA3169625A1 (en) * 2020-02-11 2021-08-19 HCW Biologics, Inc. Chromatography resin and uses thereof
US12024545B2 (en) 2020-06-01 2024-07-02 HCW Biologics, Inc. Methods of treating aging-related disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5589173A (en) * 1986-11-04 1996-12-31 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB9115364D0 (en) 1991-07-16 1991-08-28 Wellcome Found Antibody
US5869046A (en) * 1995-04-14 1999-02-09 Genentech, Inc. Altered polypeptides with increased half-life
PT833911E (pt) * 1995-06-07 2004-09-30 Ortho Mcneil Pharm Inc Anticorpos anti-factor tecidular enxertados com cdr e metodos para a sua utilizacao
US5986065A (en) * 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
HUP0100813A3 (en) * 1998-02-25 2003-08-28 Lexigen Pharmaceuticals Corp L Enhancing the circulating half-life of antibody-based fusion proteins
AU2001250814B2 (en) * 2000-03-16 2007-02-15 Genentech, Inc. Anti-tissue factor antibodies with enhanced anticoagulant potency

Also Published As

Publication number Publication date
DK1446157T3 (da) 2011-03-21
CN1599624A (zh) 2005-03-23
DE60238782D1 (de) 2011-02-10
KR20050040844A (ko) 2005-05-03
TWI338009B (en) 2011-03-01
CA2465325C (en) 2014-08-05
JP2006503541A (ja) 2006-02-02
CA2465325A1 (en) 2003-05-08
EP1446157B1 (en) 2010-12-29
KR100951432B1 (ko) 2010-04-07
CN100575364C (zh) 2009-12-30
JP4439914B2 (ja) 2010-03-24
WO2003037911A3 (en) 2003-12-31
EP1446157A2 (en) 2004-08-18
EP1446157A4 (en) 2005-12-28
WO2003037911A2 (en) 2003-05-08
ATE493148T1 (de) 2011-01-15

Similar Documents

Publication Publication Date Title
HK1068798A1 (en) Antibodies for inhibiting blood coagulation and methods of use thereof
HK1029123A1 (en) Antibodies for inhibiting blood coagulation and methods of use thereof
WO2004016750A3 (en) FcϜRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
SG146696A1 (en) Humanized antibodies against vascular endothelial growth factor
TN2010000201A1 (en) Anti-hepcidin antibodies and uses thereof
WO2002060955A3 (en) Modified antibodies and methods of use
WO2002074337A8 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
IS8432A (is) Mótefni sem bindast viðtaka hvítfrumuboða-4
WO2005102387A3 (en) Therapeutic use of anti-cs1 antibodies
RS20060234A (xx) Potpuno humana antitela za humani 4-1bb (cd137)
UA90457C2 (ru) Человеческое моноклональное антитело, которое специфически связывается с м-csf человека и блокирует связывание м-csf с с-fms
WO2003072736A3 (en) Reagents and treatment methods for autoimmune diseases
MXPA06012601A (es) Anticuerpos especificos de fcy riib humanizados y metodos de uso de los mismos.
WO2003100033A3 (en) ANTI-αvβ6 ANTIBODIES
AU3327701A (en) Humanized anti-ccr2 antibodies and methods of use therefor
MA33402B1 (fr) Compositions et procédés de ciblage de la proteine c3b de complément par des anticorps
DK1194528T3 (da) Monoklonalt antistof mod faktor VII, hvilket antistof selv ved forekomst i molært overskud kun delvist inaktiverer faktor VII, samt fremgangsmåde til produktion af et sådant antistof
WO2002074251A3 (en) Monoclonal antibody therapy for pancreas cancer
WO2007032804A3 (en) Novel uses for anti-ige therapy
WO2006095180A3 (en) Humananized monoclonal antibodies against sars - associated coronavirus and treatment of patients with sars
WO2004073649A3 (en) Clk-peptide and slk-peptide
HUP0301804A2 (hu) Antitrombotikus ágensek
WO2004087734A3 (en) Stq-peptides
EP1804789A4 (en) METHOD FOR TREATING PREECLAMPSY IN HUMANS WITH RESIBUFAGENIN

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE NAME OF INVENTOR FROM JIAO, JIAN-AN TO JIAO, JIN-AN

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191029